K-ras and rho A mutations in malignant pleural effusion

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Kristen ras (K-ras) gene mutations are linked to human lung cancer pathogenesis, particularly adenocarcinoma.
• K-ras codon 12 mutations are detectable in cell-free fluids via enriched polymerase chain reaction (PCR).
• Rho A codon 14 mutations are also proposed as oncogenic, analogous to K-ras mutations.

Purpose of the Study:

• To investigate the presence of K-ras codon 12 and rho A codon 14 point mutations in pleural effusion specimens.
• To assess the utility of pleural effusion as a diagnostic sample for oncogene mutations in lung cancer.

Main Methods:

• Enriched polymerase chain reaction (PCR) technique was employed.
• Specimens analyzed included pleural effusion from 40 patients with various causes of effusion.
• Mutations in K-ras codon 12 and rho A codon 14 were specifically targeted.

Main Results:

• K-ras codon 12 mutations were identified in 4/14 adenocarcinomas, 1/3 squamous cell carcinomas, 1/1 large cell carcinoma, and 1/5 metastatic lung tumors.
• Rho A codon 14 mutations were not detected in any of the examined pleural effusion samples.
• The study confirmed the feasibility of detecting K-ras mutations in pleural effusion.

Conclusions:

• Pleural effusion is a useful clinical specimen for detecting point mutations of oncogenes.
• K-ras codon 12 mutations are readily detectable in pleural effusion, aiding in the diagnosis of malignant pleural effusion.
• The rho A mutation was not found in this cohort, suggesting K-ras mutations are more relevant in this context.